For open label studies, CSI can deliver directly to sites in a fast, reliable and cost-effective manner. Our service helps to optimise your operations and save resources.
What is it?
Ensuring medication is available where it’s needed
We work closely with project managers to assist with trial forecasts and ensure medication is available at the sites as needed. This is a particularly attractive way of supplying to clinical trials. Supplying expensive oncology products and minimising wastage is of great importance.
In addition, patient recruitment dictates what medication is required at sites. Our flexible and adaptive solutions ensure that we can deliver fast all over the world. No patient should be turned down due to lack of medication and direct to site distribution ensures products are available.
How do we do it?
An integrated approach to distribution
Our global reach and experience in shipping to countries all over the world ensure we distribute directly to site effectively. We have an integrated approach to direct to site that combines our expertise in supply management and distribution.
Our distribution strategy and supply chain management expertise ensure products are shipped effectively. Temperature controls are in place to keep medication safe and secure during transport.